🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
As part of a post-approval commitment, the Korean health authority requests...
Status
Completed
Location
Research Site
Start Date
2024-05-28
Trial ID
NCT06448715
The aim of this study is to determine whether a single dose of eculizumab c...
Status
Unknown
Location
West China Hospital, Sichuan University
Start Date
2024-07
Trial ID
NCT06453135
Treatments Being Tested
The purpose of this study is to test whether a dosing regimen of eculizumab...
Status
Terminated
Location
Mayo Clinic
Start Date
2010-03
Trial ID
NCT01106027
Treatments Being Tested
The purpose of this study is to evaluate the long-term safety of eculizumab...
Status
Completed
Location
Stanford University Medical Center, Division of Hematology
Start Date
2005-05
Trial ID
NCT00122317
Treatments Being Tested
The objective of this study is to evaluate the safety and efficacy of eculi...
Status
Terminated
Location
Clinical Trial Site
Start Date
2020-01-14
Trial ID
NCT04155424
Treatments Being Tested
Hematopoietic stem cell transplantation (HCT)-associated thrombotic microan...
Status
Completed
Location
Children's Hospital Los Angeles (CHLA)
Start Date
2018-08-03
Trial ID
NCT03518203
Treatments Being Tested
Membranoproliferative glomerulonephritis (MPGN) is the third or fourth lead...
Status
Completed
Location
Ospedale Pediatrico "Giovanni XXIII" - U:O Nefrologia
Start Date
2014-03
Trial ID
NCT02093533
Treatments Being Tested
A study to assess the safety and efficacy of eculizumab in Japanese patient...
Status
Completed
Location
Multiple Locations
Start Date
2007-11
Trial ID
NCT01192399
Treatments Being Tested
This study aims to evaluate the efficacy and safety of different monoclonal...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-10-01
Trial ID
NCT07182409
The primary objective is to evaluate the safety and efficacy of eculizumab ...
Status
Completed
Location
City of Hope National Medical Center, Div. of Hematology & Bone Marrow Transplant
Start Date
2004-10
Trial ID
NCT00122330
Treatments Being Tested